Skip to content
NBDC Human Database

No datasets in the cart.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Research ID

hum0197-v20Release info

This page is a past version (v20). The latest version is v31.
Latest version (v31)

Research title

Elucidation of disease state by multi-layered omics analysis

Research overview

Aims
Elucidation of disease biology based on trans-omics analysis, GWAS in the Japanese and trans-ethnic populations, Elucidation of the mechanism of COVID-19 severity, Improving the performance of type 2 diabetes polygenic predictions, Elucidation of the genetic architecture of recurrent pregnancy loss
Methods
Metagenome shotgun sequencing, genome-wide association study (GWAS), small RNA-seq and eQTL analyses
Participants/materials
Metagenomic data of gut microbiome in the Japanese population (95 + 103 + 227 + 30 + 136 individuals)
Autoimmune pulmonary alveolar proteinosis cases: 198, Control participants: 395
Populations: Biobank Japan (n = 179,000), UK biobank (n = 361,000), and FinnGen (n = 136,000), Phenotypes: 220
141 Japanese individuals
Metagenomic data of gut microbiome in Inflammatory Bowel Disease (35 Ulcerative Colitis and 39 Crohn's disease) and 40 Healthy controls
Intracranial germ cell tumors cases: 133, Control participants: 762
Populations: Biobank Japan (n = 161,801) and UK biobank (n = 377,583), Phenotypes: 9
PBMC from Japanese population (COVID-19: n = 30 + 43, Healthy controls: n = 31 + 44)
Microbial genome: Metagenome-Assembled Genome (MAG), Viral genome, CRISPR spacers
Metagenomic data of gut microbiome in the Japanese population (88 + 5 individuals) and healthy individuals (n = 73)
BioBank Japan (n=180,215), UK Biobank (n=377,441), and large-scale meta-analysis including the summary statistics of other cohorts [FinnGen, Breast Cancer Association Consortium (BCAC), and Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL)] for breast and prostate cancer (n=648,746 and 482,080), Phenotypes: 15
Hunner-type interstitial cystitis cases: 144, Control participants: 41,516
524 Japanese individuals for gut microbiome-host genome association analysis, 362 Japanese individuals for plasma metabolite-host genome association analysis
The weights of variants existing in the target cohorts, Tohoku Medical Megabank and the second cohort of BBJ, calculated from GWAS results on 27,642 type 2 diabetes cases and 70,242 controls from BioBank Japan and UK Biobank
Recurrent pregnancy loss cases: 1,728, Control participants: 24,315
URL
N/A

Datasets

The list is the one this version published; each dataset's content is shown as it is now.

CartDataset IDType of dataPlatformsAccess criteriaDate published
JGAD000290Metagenome
  • Illumina HiSeq 3000
  • Illumina NovaSeq 6000
Controlled-access (Type I)2020-09-28
JGAD000363Metagenome
  • Illumina HiSeq 3000
  • Illumina NovaSeq 6000
Controlled-access (Type I)2020-11-27
JGAD000427Metagenome
  • Illumina HiSeq 3000
  • Illumina NovaSeq 6000
Controlled-access (Type I)2021-07-31
JGAD000532Metagenome
  • Illumina HiSeq 3000
  • Illumina NovaSeq 6000
Controlled-access (Type I)2021-12-10
JGAD000649Metagenome
  • Illumina HiSeq 3000
  • Illumina NovaSeq 6000
Controlled-access (Type I)2022-05-20
JGAD000650Metagenome
  • Illumina HiSeq 3000
  • Illumina NovaSeq 6000
Controlled-access (Type I)2022-05-20
NHA000154GWAS for autoimmune pulmonary alveolar proteinosis
  • Illumina Infinium Asian Screening Array
Unrestricted-access2020-11-27
NHA000162GWAS for 215 phenotypes
  • Applied Biosystems UK BiLEVE Axiom Array
  • Applied Biosystems UK Biobank Axiom Array
  • Illumina HumanExome
Unrestricted-access2021-03-22
NHA000164GWAS for 10 phenotypes
  • Illumina HumanExome
  • Illumina HumanOmniExpress
  • Illumina HumanOmniExpressExome
Unrestricted-access2021-12-21
NHA000163Fine-mapping for 79 phenotypes
  • Illumina HumanExome
  • Illumina HumanOmniExpress
  • Illumina HumanOmniExpressExome
Unrestricted-access2021-12-21
JGAD000621Read count data of miRNA
  • Illumina HiSeq 2500
Controlled-access (Type I)2022-02-21
NHA000166eQTL data
  • Illumina HiSeq 2500
  • Illumina HiSeq X
Unrestricted-access2022-02-08
NHA000171GWAS for intracranial germ cell tumors
  • Illumina Infinium Asian Screening Array
Unrestricted-access2022-06-10
NHA000173GWAS for 9 phenotypes
  • Applied Biosystems UK BiLEVE Axiom Array
  • Applied Biosystems UK Biobank Axiom Array
  • Illumina HumanExome
Unrestricted-access2022-06-16
JGAD000662Raw sequencing data of single-cell RNA-seq
  • Illumina NovaSeq 6000
Controlled-access (Type I)2022-07-19
JGAD000722Raw sequencing data of single-cell RNA-seq, clinical data
  • Illumina NovaSeq 6000
Controlled-access (Type I)2023-02-14
DRA014186MAG, Viral genome and CRISPR spacers of Microbial genome
  • Illumina HiSeq 2500
  • Illumina HiSeq 3000
  • Illumina NovaSeq 6000
Unrestricted-access2022-06-06
DRA014188MAG, Viral genome and CRISPR spacers of Microbial genome
  • Illumina HiSeq 2500
  • Illumina HiSeq 3000
  • Illumina NovaSeq 6000
Unrestricted-access2022-06-06
DRA014191MAG, Viral genome and CRISPR spacers of Microbial genome
  • Illumina HiSeq 2500
  • Illumina HiSeq 3000
  • Illumina NovaSeq 6000
Unrestricted-access2022-06-06
DRA014192MAG, Viral genome and CRISPR spacers of Microbial genome
  • Illumina HiSeq 2500
  • Illumina HiSeq 3000
  • Illumina NovaSeq 6000
Unrestricted-access2022-06-06
DRA006684MAG, Viral genome and CRISPR spacers of Microbial genome
  • Illumina HiSeq 2500
  • Illumina HiSeq 3000
  • Illumina NovaSeq 6000
Unrestricted-access2019-02-01
DRA014184MAG, Viral genome and CRISPR spacers of Microbial genome
  • Illumina HiSeq 2500
  • Illumina HiSeq 3000
  • Illumina NovaSeq 6000
Unrestricted-access2022-06-06
NHA000178MAG, Viral genome and CRISPR spacers of Microbial genome
  • Illumina HiSeq 2500
  • Illumina HiSeq 3000
  • Illumina NovaSeq 6000
Unrestricted-access2022-12-01
NHA000179MAG, Viral genome and CRISPR spacers of Microbial genome
  • Illumina HiSeq 2500
  • Illumina HiSeq 3000
  • Illumina NovaSeq 6000
Unrestricted-access2022-12-01
NHA000177MAG, Viral genome and CRISPR spacers of Microbial genome
  • Illumina HiSeq 2500
  • Illumina HiSeq 3000
  • Illumina NovaSeq 6000
Unrestricted-access2022-12-01
JGAD000729Metagenome
  • Illumina HiSeq 3000
  • Illumina NovaSeq 6000
Controlled-access (Type I)2023-03-30
NHA000187GWAS for 15 phenotypes
  • Applied Biosystems UK BiLEVE Axiom Array
  • Applied Biosystems UK Biobank Axiom Array
  • Illumina HumanExome
Unrestricted-access2023-06-06
NHA000188GWAS for Hunner-type interstitial cystitis
  • Illumina Infinium Asian Screening Array
Unrestricted-access2023-06-27
NHA000190GWAS for gut microbiome
GWAS for plasma metabolite
GWAS for KEGG Gene Ortholog and KEGG Pathway
  • Illumina HiSeq 2500
  • Illumina HiSeq 3000
  • Illumina HiSeq X
Unrestricted-access2023-10-02
NHA000191The weights of variants calculated from GWAS results on type 2 diabetes
  • Applied Biosystems UK BiLEVE Axiom Array
  • Applied Biosystems UK Biobank Axiom Array
  • Illumina HumanExome
Unrestricted-access2024-05-29
NHA000192GWAS for recurrent pregnancy loss
  • Illumina Infinium Asian Screening Array
Unrestricted-access2024-05-30

Data provider

Principal investigator
Yukinori Okada
Affiliation
Department of Statistical Genetics, Osaka University Graduate School of Medicine

Research projects

No research projects.

Grants

NameTitleProject number
Precursory Research for Innovative Medical care (PRIME), Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED)
Crosstalk among microbiome, host, disease, and drug discovery enhanced by statistical genetics
  • JP19gm6010001
FORCE, Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED)
Elucidation of disease-specific microbiota and personalized medicine by metagenome-wide association studies
  • JP20gm4010006
Practical Research Project for Rare / Intractable Diseases, Japan Agency for Medical Research and Development (AMED)
Biology and in silico drug repositioning of pulmonary alveolar proteinosis using trans-layer omics analysis
  • JP20ek0109413
Practical Research Project for Allergic Diseases and Immunology, Japan Agency for Medical Research and Development (AMED)
Nucleic genome drug discovery for autoimmune diseases through in-silico and patient-oriented screening utilizing large-scale disease genetics
  • JP19ek0410041
Practical Research Project for Allergic Diseases and Immunology, Japan Agency for Medical Research and Development (AMED)
Genomic prediction medicine of rheumatoid arthritis based on comprehensive immune-omics resources
  • JP21ek0410075
Platform Program for Promotion of Genome Medicine, Japan Agency for Medical Research and Development (AMED)
Implementation of genomic prediction medicine based on statistical genetics
  • JP21km0405211
Platform Program for Promotion of Genome Medicine, Japan Agency for Medical Research and Development (AMED)
Next-generation genomics analyses elucidates biology, personalized medicine, and drug discovery of psoriasis
  • JP21km0405217
KAKENHI Grant-in-Aid for Scientific Research (A)
Elucidation of disease biology and tissue specificity by trans-layer omics analysis and whole-genome sequencing
  • 19H01021
KAKENHI Grant-in-Aid for Scientific Research (A)
Elucidation of immune and allergic disease dynamics by integrative sequencing analysis
  • 22H00476

Related publications

TitleDOIDataset ID
Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population.
Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis.
A metagenome-wide association study of gut microbiome in patients with multiple sclerosis revealed novel disease pathology.
A global atlas of genetic associations of 220 deep phenotypes
Metagenome-wide association study revealed disease-specific landscape of the gut microbiome of systemic lupus erythematosus in Japanese
Whole gut virome analysis of 476 Japanese revealed a link between phage and autoimmune disease
Insights from complex trait fine-mapping across diverse populations
Genetic architecture of microRNA expression and its link to complex diseases in the Japanese population.
Multi-trait and cross-population genome-wide association studies across autoimmune and allergic diseases identify shared and distinct genetic components.
DOCK2 is involved in the host genetics and biology of severe COVID-19
Prokaryotic and viral genomes recovered from 787 Japanese gut metagenomes revealed microbial features linked to diets, populations, and diseases
Reconstruction of the personal information from human genome reads in gut metagenome sequencing data
Pan-cancer and cross-population genome-wide association studies dissect shared genetic backgrounds underlying carcinogenesis
Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity
Genome-wide association analysis identifies susceptibility loci within the major histocompatibility complex region for Hunner-type interstitial cystitis
Analysis of gut microbiome, host genetics, and plasma metabolites reveals gut microbiome-host interactions in the Japanese population
Body mass index stratification optimizes polygenic prediction of type 2 diabetes in cross-biobank analyses
Common and rare genetic variants predisposing females to unexplained recurrent pregnancy loss

Controlled access users

Principal investigatorAffiliationCountry/RegionResearch titlePeriod of data useDataset ID
Ilana BritoMeinig School of Biomedical Engineering, Cornell UniversityNew York, United StatesComparative metagenomics of lupus patients' microbiomes (Protocol Number IRB0144130)2022-05-12 – 2025-01-08
Yongxin LIThe department of Chemistry, The University of Hong KongChinaComparison of gut bacterial diversity and composition in MS/EAE2022-09-26 – 2025-06-09
Michiaki HamadaHamada Laboratory, Faculty of Science and Engineering, Waseda UniversityJapanConstruction of RNA-targeted Drug Discovery Database2023-01-05 – 2027-10-31
Tina FuchsInstitute for Clinical Chemistry, Medical Faculty Mannheim, Heidelberg UniversityGermanyInvestigating the clonality of VIREM cells in COVID-19 patients2024-02-26 – 2025-04-14
Koichi MatsudaClinical genome sequencing, The University of TokyoJapanDisease Cohort Research Network for Disease Marker Exploratory Studies2024-06-17 – 2029-03-31
Yuhei KiritaDepartment of Nephrology, Kyoto Prefectural University of MedicineJapanElucidation of the Pathogenesis through Comparative Analysis of Peripheral Blood Gene Expression in IgA Nephropathy and Immune-related Diseases2025-07-29 – 2030-03-31